|
brain - pathology |
11 |
|
magnetic resonance imaging |
11 |
|
schizophrenia |
11 |
|
psychosis |
10 |
|
dti |
9 |
|
mri |
9 |
|
brain - ultrastructure |
8 |
|
diffusion tensor imaging |
8 |
|
drug-naive |
8 |
|
first episode |
8 |
|
fractional anisotropy |
8 |
|
panss |
8 |
|
psychiatric status rating scales |
8 |
|
schizophrenia - pathology |
8 |
|
schizophrenic psychology |
8 |
|
temporal lobe - ultrastructure |
8 |
|
voxel-based morphometry |
8 |
|
behavior, animal |
7 |
|
disease models, animal |
7 |
|
lateral ventricles |
7 |
|
magnetic resonance imaging - methods |
7 |
|
maternal exposure |
7 |
|
meta-analysis |
7 |
|
parkinson's disease |
7 |
|
schizophrenia - drug therapy - pathology |
7 |
|
alff |
6 |
|
anti-psychotics |
6 |
|
antipsychotic agents - pharmacology - therapeutic use |
6 |
|
brain |
6 |
|
brain - drug effects - metabolism - pathology |
6 |
|
caudate |
6 |
|
diffusivity |
6 |
|
drug naïve |
6 |
|
functional connectivity |
6 |
|
functional mri |
6 |
|
hong kong |
6 |
|
locomotion |
6 |
|
longitudinal |
6 |
|
multimodal |
6 |
|
naturalistic |
6 |
|
neuronal plasticity - drug effects |
6 |
|
prepulse inhibition |
6 |
|
resting state |
6 |
|
schizophrenia - drug therapy - physiopathology |
6 |
|
tspyl2 |
6 |
|
visual hallucinations |
6 |
|
visual spatial memory |
6 |
|
adult |
5 |
|
amygdala |
5 |
|
antipsychotic |
5 |
|
anxiety |
5 |
|
bipolar |
5 |
|
brain - enzymology - pathology |
5 |
|
brain - pathology - physiopathology |
5 |
|
cnpase |
5 |
|
dementia |
5 |
|
depression |
5 |
|
depressive disorder, major - diagnosis - epidemiology - psychology |
5 |
|
diffusion |
5 |
|
diffusion magnetic resonance imaging |
5 |
|
diffusion tensor imaging - methods |
5 |
|
disease outbreaks |
5 |
|
fa |
5 |
|
females |
5 |
|
health care workers |
5 |
|
health personnel - psychology |
5 |
|
health personnel - statistics and numerical data |
5 |
|
hippocampus |
5 |
|
image processing, computer-assisted |
5 |
|
image processing, computer-assisted - methods |
5 |
|
infectious disease outbreak |
5 |
|
iron deposition |
5 |
|
long-term psychological distress |
5 |
|
nerve net - pathology - physiopathology |
5 |
|
never medicated |
5 |
|
outbreak |
5 |
|
polyic |
5 |
|
posttraumatic symptoms |
5 |
|
prefrontal-striatal-limbic circuits |
5 |
|
pregnancy complications, infectious - immunology |
5 |
|
prenatal exposure delayed effects |
5 |
|
quantitative susceptibility mapping |
5 |
|
remission |
5 |
|
sars |
5 |
|
schizophrenia, first-episode |
5 |
|
severe acute respiratory syndrome |
5 |
|
severe acute respiratory syndrome - epidemiology - psychology |
5 |
|
sickness impact profile |
5 |
|
stress |
5 |
|
stress disorders, post-traumatic - diagnosis - epidemiology - etiology |
5 |
|
stress disorders, post-traumatic - diagnosis - epidemiology - psychology |
5 |
|
striato-thalamic volume |
5 |
|
structural |
5 |
|
survivors - psychology - statistics and numerical data |
5 |
|
vbm |
5 |
|
alen |
4 |
|
antipsychotic agents - administration and dosage - pharmacology - therapeutic use |
4 |
|
antipsychotic agents - therapeutic use |
4 |
|
antipsychotics |
4 |
|
autistic disorder - complications |
4 |
|
autistic disorder - diagnosis - etiology - pathology |
4 |
|
autistic disorder - pathology |
4 |
|
basal ganglia - pathology |
4 |
|
brain - growth and development |
4 |
|
brain structure |
4 |
|
chi-square distribution |
4 |
|
children |
4 |
|
computational biology |
4 |
|
congenital abnormalities - diagnosis - pathology |
4 |
|
corpus callosum - pathology |
4 |
|
diffusion tensor |
4 |
|
disease progression |
4 |
|
family history |
4 |
|
frontal lobe - pathology |
4 |
|
head - abnormalities - pathology |
4 |
|
infectious disease transmission, patient-to-professional |
4 |
|
morphometry |
4 |
|
mri scan |
4 |
|
neuroleptic naive |
4 |
|
pharmacy and pharmacology psychology |
4 |
|
psychology pharmacy and pharmacology |
4 |
|
putamen |
4 |
|
putamen - drug effects - pathology |
4 |
|
schizophrenia - diagnosis - etiology - pathology |
4 |
|
schizophrenia - genetics - pathology |
4 |
|
severe acute respiratory syndrome - epidemiology - transmission |
4 |
|
stress, psychological - epidemiology |
4 |
|
students, medical - psychology |
4 |
|
students, nursing - psychology |
4 |
|
subtraction analysis |
4 |
|
treatment outcome |
4 |
|
voxel-based analysis |
4 |
|
ale |
3 |
|
asperger |
3 |
|
asperger syndrome - diagnosis - pathology - psychology |
3 |
|
attention deficit disorder with hyperactivity - diagnosis - epidemiology |
3 |
|
attention deficit-hyperactivity disorder |
3 |
|
autism |
3 |
|
autistic disorder - diagnosis - pathology - psychology |
3 |
|
brain - abnormalities |
3 |
|
brain mapping |
3 |
|
chinese |
3 |
|
cognition disorders - diagnosis - epidemiology |
3 |
|
depressive disorder, major - epidemiology |
3 |
|
diagnostic and statistical manual of mental disorders |
3 |
|
functional |
3 |
|
gray matter |
3 |
|
grey matter |
3 |
|
health personnel - psychology - statistics and numerical data |
3 |
|
language |
3 |
|
language development disorders - pathology |
3 |
|
magnetic resonance imaging - methods - psychology |
3 |
|
mental health |
3 |
|
neuroanatomy |
3 |
|
neuroimaging - methods - psychology |
3 |
|
occupational diseases - epidemiology |
3 |
|
occupational exposure - statistics and numerical data |
3 |
|
patients |
3 |
|
psychological |
3 |
|
psychometrics - statistics and numerical data |
3 |
|
severe acute respiratory syndrome - epidemiology |
3 |
|
severe acute respiratory syndrome - psychology |
3 |
|
stress, psychological |
3 |
|
voxel-based |
3 |
|
advance directives |
2 |
|
antipsychotic agents - adverse effects - pharmacology - therapeutic use |
2 |
|
bazett's correction |
2 |
|
besa |
2 |
|
cerebral |
2 |
|
cerebral laterality |
2 |
|
cerebral ventricles - abnormalities |
2 |
|
databases, factual |
2 |
|
dichotic listening |
2 |
|
electroencephalography |
2 |
|
emotion |
2 |
|
endophenotype |
2 |
|
faces |
2 |
|
functional laterality |
2 |
|
humans |
2 |
|
living wills |
2 |
|
long qt syndrome - chemically induced |
2 |
|
pharmacy and pharmacology |
2 |
|
qt interval |
2 |
|
questionnaires |
2 |
|
risk |
2 |
|
schizophrenia - diagnosis |
2 |
|
schizophrenia - drug therapy |
2 |
|
second-generation antipsychotics |
2 |
|
students, medical |
2 |
|
time factors |
2 |
|
volume |
2 |
|
volumetric |
2 |
|
brain - blood supply - physiopathology |
1 |
|
brain damage, chronic - diagnosis - physiopathology - psychology |
1 |
|
carrier |
1 |
|
cerebrovascular circulation |
1 |
|
corpus callosum |
1 |
|
deception |
1 |
|
delirium, dementia, amnestic, cognitive disorders - diagnosis - physiopathology - psychology |
1 |
|
diagnostic imaging |
1 |
|
ethics, medical |
1 |
|
familial |
1 |
|
food |
1 |
|
hallucinations - physiopathology |
1 |
|
imaging |
1 |
|
informed consent - legislation & jurisprudence |
1 |
|
male |
1 |
|
mental competency |
1 |
|
neurodevelopmental |
1 |
|
neuroimaging |
1 |
|
neuropsychological tests |
1 |
|
neuropsychology |
1 |
|
pharmaceutical preparations - administration & dosage |
1 |
|
physiopathology |
1 |
|
reproducibility of results |
1 |
|
schizophrenia - diagnosis - pathology - physiopathology |
1 |
|
severity of illness index |
1 |
|
structure |
1 |
|
tomography, emission-computed |
1 |
|
volition - physiology |
1 |
